SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061544
Filing Date
2023-11-09
Accepted
2023-11-09 07:55:23
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q wve-20230930.htm   iXBRL 10-Q 2043725
2 EX-10.1 wve-ex10_1.htm EX-10.1 43370
3 EX-31.1 wve-ex31_1.htm EX-31.1 17243
4 EX-31.2 wve-ex31_2.htm EX-31.2 17566
5 EX-32 wve-ex32.htm EX-32 12909
6 GRAPHIC img56423468_0.jpg GRAPHIC 47926
7 GRAPHIC img56423468_1.jpg GRAPHIC 216369
  Complete submission text file 0000950170-23-061544.txt   6173251

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wve-20230930.xsd EX-101.SCH 33451
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wve-20230930_lab.xml EX-101.LAB 302099
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wve-20230930_pre.xml EX-101.PRE 205661
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT wve-20230930_cal.xml EX-101.CAL 39019
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT wve-20230930_def.xml EX-101.DEF 117613
42 EXTRACTED XBRL INSTANCE DOCUMENT wve-20230930_htm.xml XML 631152
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 231390119
SIC: 2834 Pharmaceutical Preparations